Retrospective evaluation of carbapenemase-producing Pseudomonas aeruginosa carriage and a proposed follow-up strategy: insights from a blaVIM-dominant setting

Postponement of the start of follow-up, for up to one year, should be considered for patients presenting with risk factors for longer CPPA carriage. This would facilitate a more economical approach to CPPA screening while minimizing the burden for patients. Follow-up may begin immediately for patients without any risk factors, and five consecutive negative screenings might be sufficient.